Altria Group shares have fallen 8.2% over the past three months, significantly underperforming the broader market. During this period, the Zacks Tobacco industry gained 1.7%, the Zacks Consumer Staples sector rose 1.2% and the S&P 500 rallied 6.4%. This divergence reflects mounting pressure on traditional cigarette volumes and heightened regulatory scrutiny of vaping products. Investors should note that Altria’s dividend yield remains above 7%, offering income support despite the recent pullback in share value.

In response to shifting consumer preferences and increased price sensitivity, Altria has accelerated its shift toward lower-priced cigarette offerings under its Basic Brand labels. Management reports that discount formats now account for approximately 15% of Altria’s overall cigarette shipments, up from 10% a year ago. This strategy has helped stabilize shipment volumes, which declined only 1.2% in the second quarter compared with a 3.5% drop in industry-wide deliveries, according to company data.

Altria continues to invest in smoke-free alternatives, maintaining its minority stake in a leading heated tobacco venture and allocating $400 million this year to e-vapor research and development. While regulatory approval timelines for new nicotine products remain uncertain, the company expects key decisions from the Food and Drug Administration on both heated tobacco systems and next-generation oral nicotine pouches by mid-2026. These upcoming milestones could provide catalysts for a rebound in investor sentiment, particularly if approvals pave the way for incremental market share gains.